Intangible Assets

McKesson’s scale and long-standing relationships with manufacturers, pharmacies, and health systems support some trust and contract stickiness, but these are more commercial than proprietary versus peers like Cencora and Cardinal Health.

The company’s distribution role benefits from regulatory and compliance know-how in pharmaceutical handling, yet those requirements are industry-wide and do not create a unique legal barrier relative to other large distributors.

Brand matters mainly as a reliability signal in a mission-critical supply chain, but customers still have credible alternatives, which limits pricing power versus peers.

No evidence of exclusive intellectual property or differentiated consumer-facing brand equity suggests intangible assets are supportive rather than decisive for moat durability.

Switching Costs

McKesson’s embedded ordering, inventory, and replenishment workflows create operational switching friction because customers would need to reconfigure procurement, compliance, and service processes to change distributors.

The company’s role in high-frequency, low-margin pharmaceutical fulfillment makes service continuity important, which raises retention versus smaller distributors that cannot match breadth and reliability.

Switching costs are reinforced by integration into pharmacy and provider systems, but they remain lower than in software-like models because large customers can still multi-source or rebid contracts.

Versus Cardinal Health and Cencora, McKesson appears similarly sticky rather than uniquely locked-in, so the moat is strong but not structurally dominant.

Network Effects

McKesson does not exhibit a meaningful direct network effect because one customer’s use of the distribution platform does not materially increase value for other customers in the way a marketplace or software ecosystem would.

Any indirect scale benefits from broader supplier and customer participation are operational rather than self-reinforcing, so they do not create durable peer-leading compounding.

Compared with peers, McKesson’s platform is large, but size alone does not convert into a true network moat without strong cross-side feedback loops.

The business is better characterized by scale logistics than by network-driven lock-in, which keeps this moat factor weak.

Cost Advantage

McKesson’s very high asset turnover and negative cash conversion cycle indicate efficient working-capital management that supports lower unit economics in a distribution model.

Large purchasing scale and dense logistics infrastructure help spread fixed costs across a broad volume base, which improves cost competitiveness versus smaller distributors.

The company’s ROIC and ROCE are strong, suggesting it can convert scale and process efficiency into superior returns relative to peers in a low-margin industry.

Cost advantage is meaningful because distribution economics reward scale, but peers such as Cencora and Cardinal Health also operate at large scale, so the edge is strong rather than exclusive.

Efficient Scale

Pharmaceutical distribution is a high-volume, low-margin business where national scale matters because duplicative networks are expensive and inefficient, which supports efficient-scale economics.

McKesson’s broad footprint and logistics density make it difficult for smaller entrants to match service levels without sacrificing economics, which protects share versus subscale competitors.

The market still supports a few large national distributors, so the moat comes from efficient scale in a concentrated industry rather than monopoly-like control.

Versus peers, McKesson is one of the core incumbents with comparable scale advantages, but the presence of other large distributors prevents a higher dominance score.

Overall Score

McKesson’s moat is strongest in switching costs, cost advantage, and efficient scale, where its distribution footprint and embedded workflows support durable retention and pricing discipline versus peers, but the absence of true network effects or unique intangible assets keeps the overall moat strong rather than exceptional.